TSC1 and neoplasm with perivascular epithelioid cell differentiation: Recent studies demonstrated TSC1/2 inactivation and m-TOR hyperactivation in non-TSC AMLs and in extrarenal PEComas using immunohistochemistry and Western blot analysis[11].